Cannabis & Medicinal Research

About Conference

15th International Conference on Cannabis & Medicinal Research, which is planned to held during May 24-25, 2027 Amsterdam, Netherlands. The principle subject of the meeting is "Cannabis Marijuana 2027" which covers wide scope of fundamentally vital sessions. It's a stage to convey all the cannabis researchers together to share their encounters. It's the amalgam of logical research just as inventive thoughts.

Addictive disarranges, for instance, substance misuse and reliance is customary issue that incorporates the maltreatment of liquor or medications. Enslavement makes after some time and is an unremitting and falling away from the faith illness.

There are three distinct terms used to characterize substance-related addictive disarranges:

Substance Abuse as a confusion, implies the misuse of unlawful substances or the oppressive use of legal substances. Alcohol is the most notable authentic medication to be mishandled.

Substance dependence is an addictive issue that depicts proceeded with utilization of medications or liquor, notwithstanding when noteworthy issues identified with their utilization have created.

Chemical dependence is also an addictive issue that depicts the pressing use of synthetic compounds (ordinarily medications or liquor) and the inability to stop using them regardless of the significant number of issues caused.

About Organization:

3000+ Global Events

25 Million+ Visitors

70000+ site visits for each individual meeting

One of a kind Opportunity! Online perceivability to the Speakers and Experts 25000+ special guests per meeting

Who ought to visit?

This one of a kind Conference will give you the chance to:

Trade research and experience

Meet and trade learning with genuine pioneers from everywhere throughout the world

Show your organization's authority in the Cannabis field

Connect with key pioneers, scholastic and industry specialists and clinicians

Raise your organization's perceivability in the field.

The primary point of the Conference is to bring the most recent data and best practices on the presentation of restorative cannabis into current proof-based prescription and to build up the utilization of therapeutic cannabis conference as a standard medicinal technique. To accomplish its point, the fifth ​International Conference on Medical Cannabis Conference is structured as an open discussion for researchers and different specialists, for professionals in the field, for example, restorative specialists, drug specialists, medicinal attendants and other paramedical staff, for patient activists, for leaders and business people, for the overall population and, to wrap things up, for the media.

Advantages of visiting:

A general review of the state and extent of the Neurology conferences business today

Current enlisting patterns including which positions are at present in most prominent interest

Increase a comprehension of how these organizations work and like to be drawn nearer

Step by step instructions to emerge as an attractive contender to a cannabis industry boss

A chance to have your inquiries replied

A choice to move up to the meeting floor, to exploit a complimentary resume survey by Viridian Staffing just as on location vocation directing in the Juana Career Lounge. On the off chance that any of CCC's exhibitors express they are contracting for a job you give off an impression of being a reasonable fit for, Viridian will guide you as needs be.

Who should sponsor/exhibit:

Pharmaceuticals

Medication Manufacturers

Emergency clinics

Instructive Institutes

Research Centers

Sessions and Tracks

Track 1: Cannabis Pharmacology and Therapeutics

This track focuses on the pharmacological properties of cannabis-derived compounds and their therapeutic applications in modern medicine. It explores cannabinoid receptor interactions, pharmacokinetics, pharmacodynamics, and dosage optimization for clinical use. Researchers will discuss emerging evidence supporting cannabis-based therapies for various medical conditions. The sessions emphasize drug efficacy, safety profiles, and personalized treatment strategies. Participants will gain insights into novel therapeutic formulations and future directions in cannabinoid pharmacology. The track bridges laboratory discoveries with evidence-based clinical practice.

Track 2: Medical Cannabis in Pain Management

Chronic pain remains one of the leading indications for medical cannabis worldwide. This track examines the effectiveness of cannabinoids in neuropathic pain, cancer pain, arthritis, fibromyalgia, and postoperative pain management. Discussions include clinical trials, prescribing guidelines, opioid-sparing strategies, and patient outcomes. Experts will evaluate the benefits and limitations of cannabis-based medicines compared to conventional analgesics. Innovative pain management protocols and patient-centered care models will also be highlighted. The sessions aim to improve safe and effective pain treatment approaches.

Track 3: Cannabinoid Chemistry and Drug Discovery

Cannabinoid chemistry continues to drive innovation in medicinal research and pharmaceutical development. This track explores the isolation, synthesis, structural characterization, and modification of natural and synthetic cannabinoids. Topics include medicinal chemistry, lead optimization, molecular design, and novel cannabinoid analogs. Researchers will present advances in analytical technologies supporting cannabinoid identification and quality assessment. Discussions also cover future opportunities for drug discovery targeting the endocannabinoid system. The track encourages collaboration between chemists and pharmaceutical scientists.

Track 4: Endocannabinoid System and Human Physiology

The endocannabinoid system plays a critical role in maintaining physiological balance throughout the body. This track explores its involvement in neurological, immune, metabolic, cardiovascular, and reproductive functions. Researchers will discuss receptor biology, endogenous cannabinoids, signaling pathways, and molecular mechanisms. Emerging evidence linking endocannabinoid dysfunction to disease progression will also be examined. Sessions focus on translational research and therapeutic interventions targeting this complex biological network. The track promotes a deeper understanding of cannabinoid science.

Track 5: Cannabis in Neurological Disorders

Neurological diseases present significant opportunities for cannabinoid-based therapies. This track highlights the role of cannabis in epilepsy, multiple sclerosis, Parkinson's disease, Alzheimer's disease, migraine, and movement disorders. Experts will review clinical evidence, neuroprotective mechanisms, patient experiences, and ongoing research. Discussions emphasize treatment outcomes, dosing strategies, and future therapeutic developments. Participants will explore innovative neurological applications of cannabinoids. The sessions support advancements in neuroscience and patient care.

Track 6: Cannabis and Mental Health

Cannabis has complex interactions with mental health that require evidence-based evaluation. This track explores its therapeutic potential in anxiety, depression, PTSD, autism spectrum disorders, and sleep disturbances while addressing psychiatric risks. Researchers will examine clinical studies, neurobiological mechanisms, and patient safety considerations. Discussions include responsible prescribing, monitoring, and individualized treatment planning. The sessions encourage balanced perspectives on benefits and limitations. New research findings will shape future psychiatric applications.

Track 7: Cannabis for Cancer Supportive Care

Cannabis-based medicines are increasingly used to improve the quality of life for cancer patients. This track focuses on symptom management, including pain, nausea, vomiting, appetite loss, cachexia, and treatment-related side effects. Researchers will discuss supportive care protocols, palliative medicine, and integrative oncology approaches. Clinical evidence regarding patient outcomes and safety will be reviewed. Emerging studies on cannabinoids and tumor biology will also be explored. The sessions promote comprehensive cancer care strategies.

Track 8: Cannabis Cultivation and Agricultural Biotechnology

High-quality medicinal cannabis begins with advanced cultivation practices and agricultural innovation. This track covers genetics, breeding, greenhouse technologies, precision agriculture, pest management, and sustainable cultivation methods. Experts will discuss Good Agricultural Practices (GAP), environmental control systems, and crop optimization. Sessions examine biotechnology applications for improving cannabinoid yield and plant resilience. Quality assurance throughout cultivation is also emphasized. The track supports sustainable medicinal cannabis production.

Track 9: Medicinal Plant Biotechnology

Biotechnology is transforming the cultivation and production of medicinal plants with improved therapeutic value. This track explores tissue culture, plant genetics, metabolic engineering, synthetic biology, and molecular breeding techniques. Researchers will discuss enhanced production of bioactive compounds and conservation of valuable medicinal species. Sessions highlight innovations that improve crop quality, consistency, and sustainability. Advances in biotechnology continue to support pharmaceutical development. The track encourages interdisciplinary scientific collaboration.

Track 10: Cannabis Extraction and Processing Technologies

Efficient extraction technologies are essential for producing safe and standardized cannabis products. This track examines supercritical CO? extraction, ethanol extraction, solventless methods, purification processes, and manufacturing innovations. Discussions include process optimization, quality control, and product stability. Researchers will present technologies that improve cannabinoid recovery and consistency. Regulatory compliance and industrial scalability will also be addressed. Participants will explore best practices in cannabis processing.

Track 11: Pharmaceutical Cannabis Formulations

Pharmaceutical innovation is expanding the range of cannabis-based dosage forms. This track focuses on oral, topical, inhaled, transdermal, injectable, and nano-formulated cannabinoid medicines. Experts will discuss formulation science, drug delivery systems, bioavailability enhancement, and controlled-release technologies. Clinical applications and manufacturing standards will also be reviewed. Emerging pharmaceutical products continue to improve therapeutic outcomes. The sessions highlight advances in precision medicine.

Track 12: Clinical Trials and Evidence-Based Cannabis Medicine

Clinical research provides the foundation for safe and effective cannabis therapeutics. This track explores randomized clinical trials, observational studies, real-world evidence, systematic reviews, and research methodologies. Discussions focus on trial design, ethical considerations, patient recruitment, and outcome assessment. Researchers will present recent clinical findings across multiple disease areas. Regulatory expectations for evidence generation will also be examined. The sessions strengthen scientific credibility in cannabis medicine.

Track 13: Cannabis Regulations and Global Policy

The regulatory landscape for cannabis continues to evolve across different regions of the world. This track examines international legislation, licensing systems, product approvals, quality standards, and compliance requirements. Experts will discuss policy development, healthcare access, and regulatory harmonization. Sessions compare national frameworks and emerging legal trends. Ethical and public health considerations are also addressed. The track supports informed policy and responsible industry growth.

Track 14: Quality Assurance and Good Manufacturing Practices

Maintaining product quality is essential throughout the medicinal cannabis supply chain. This track focuses on GMP compliance, quality management systems, contamination control, stability testing, and product standardization. Researchers and industry professionals will discuss laboratory validation and regulatory inspections. Analytical testing ensures consistency, potency, and consumer safety. Best manufacturing practices will be highlighted through real-world examples. The sessions strengthen quality-focused production.

Track 15: Cannabis Analytical Sciences

Advanced analytical technologies ensure the safety, potency, and purity of cannabis products. This track explores chromatography, mass spectrometry, spectroscopy, and laboratory quality assurance. Discussions include cannabinoid profiling, terpene analysis, contaminant detection, and method validation. Researchers will present innovative analytical tools for pharmaceutical and research applications. Standardization and laboratory accreditation remain central themes. The track promotes scientific accuracy and product reliability.

Track 16: Cannabinoids and Immunology

Cannabinoids have significant effects on immune regulation and inflammatory pathways. This track examines their role in autoimmune diseases, inflammatory disorders, immune modulation, and infectious diseases. Researchers will discuss molecular mechanisms, receptor biology, and therapeutic opportunities. Clinical evidence supporting cannabinoid-based immune therapies will be evaluated. Future translational research directions will also be explored. The sessions foster collaboration between immunologists and cannabinoid researchers.

Track 17: Cannabis and Women's Health

Women's health represents a growing area of cannabinoid research and clinical application. This track explores menstrual disorders, endometriosis, menopause, reproductive health, pregnancy considerations, and chronic pelvic pain. Researchers will discuss current evidence, patient safety, and individualized treatment approaches. Emerging studies on hormonal interactions and women's healthcare needs will be highlighted. Sessions encourage evidence-based clinical decision-making. The track advances gender-specific cannabis research.

Track 18: Cannabis in Pediatric Medicine

Pediatric cannabinoid therapy requires careful scientific evaluation and clinical oversight. This track focuses on treatment-resistant epilepsy, neurological disorders, rare diseases, and supportive pediatric care. Discussions include clinical evidence, dosing considerations, ethical challenges, and long-term safety monitoring. Researchers will present recent advancements in pediatric cannabinoid research. Family-centered healthcare approaches will also be explored. The sessions support safe and responsible pediatric applications.

Track 19: Precision Medicine and Personalized Cannabinoid Therapy

Personalized medicine is transforming cannabinoid treatment strategies for diverse patient populations. This track explores pharmacogenomics, biomarkers, individualized dosing, patient stratification, and precision healthcare approaches. Researchers will discuss genetic influences on cannabinoid response and therapeutic effectiveness. Clinical decision-support tools and digital health technologies will also be examined. Sessions emphasize optimized patient outcomes through tailored treatment. The track supports future precision cannabinoid medicine.

Track 20: Cannabis and Integrative Healthcare

Integrative healthcare combines conventional medicine with complementary therapeutic approaches. This track examines how cannabis can be incorporated into multidisciplinary treatment plans alongside rehabilitation, nutrition, physical therapy, and supportive care. Researchers will discuss collaborative clinical models and patient-centered outcomes. Evidence supporting integrative medicine practices will be reviewed. Safety, communication, and healthcare coordination remain key themes. The sessions promote holistic patient management.

Track 21: Artificial Intelligence in Cannabis Research

Artificial intelligence is accelerating innovation across cannabis research and pharmaceutical development. This track explores AI applications in drug discovery, predictive modeling, cultivation optimization, precision agriculture, and clinical data analysis. Researchers will discuss machine learning for cannabinoid identification and personalized medicine. Digital technologies supporting healthcare decision-making will also be highlighted. AI-driven research continues to improve efficiency and scientific discovery. The track showcases future technological advancements.

Track 22: Industrial Hemp and Sustainable Applications

Industrial hemp offers significant opportunities beyond medicinal cannabinoid production. This track explores hemp-derived biomaterials, textiles, construction materials, nutrition, biofuels, cosmetics, and environmental sustainability. Researchers will discuss agricultural innovations and circular economy approaches. Emerging industrial applications continue to expand global markets. Environmental benefits and sustainable production practices will also be examined. The sessions promote responsible hemp utilization.

Track 23: Natural Products and Herbal Drug Development

Natural products remain an essential source of modern pharmaceutical innovation. This track explores medicinal plant discovery, phytochemistry, herbal formulations, bioactive compounds, and botanical drug development. Researchers will discuss traditional knowledge integrated with contemporary scientific validation. Quality assurance and clinical evidence supporting herbal medicines will also be emphasized. Novel therapeutic candidates continue to emerge from natural resources. The sessions encourage multidisciplinary collaboration.

Track 24: Cannabis Toxicology and Patient Safety

Patient safety remains fundamental to the responsible use of cannabis-based therapies. This track focuses on toxicology, adverse effects, drug interactions, overdose management, pharmacovigilance, and long-term safety monitoring. Researchers will discuss risk assessment and clinical guidelines for safe prescribing. Regulatory safety standards and post-marketing surveillance will also be reviewed. Evidence-based approaches improve healthcare decision-making. The sessions strengthen patient protection.

Track 25: Translational Cannabis Research

Translational research connects laboratory discoveries with clinical implementation and public health impact. This track explores biomarker discovery, preclinical models, therapeutic validation, and multidisciplinary collaboration. Researchers will present strategies for accelerating innovation from bench to bedside. Discussions include commercialization, regulatory pathways, and healthcare adoption. Emerging translational studies continue to advance cannabinoid medicine. The sessions encourage collaborative scientific progress.

Track 26: Future Perspectives in Cannabis and Medicinal Research

The future of cannabis research is driven by innovation, collaboration, and scientific excellence. This track highlights emerging technologies, global partnerships, next-generation therapeutics, policy evolution, and future research priorities. Experts will discuss opportunities for expanding clinical applications and improving patient access. Sessions examine evolving market trends, research funding, and interdisciplinary collaboration. Participants will gain valuable insights into the future direction of cannabinoid science. This concluding track inspires continued advancement in cannabis and medicinal research.

Market Analysis

Cannabis Marijuana 2027 invites participants, moderators, and exhibitors from everywhere throughout the world. We are charmed to welcome all of you to visit and enroll for the  15th International Conference on Cannabis & Medicinal Research which will be held on May 24-25, 2027 Amsterdam, Netherlands.

The arranging panel is preparing for an energizing and enlightening gathering program including entire addresses, symposia, workshops on an assortment of themes, blurb introductions and different projects for members from everywhere throughout the world. We welcome you to go along with us at the Cannabis Marijuana 2027, where you will make certain to have an important involvement with researchers from around the globe. All individuals from the Cannabis Marijuana-2027 sorting out board of trustees anticipate meet you in Sydney, Australia.

Significance and Scope:-

5th  International Conference on Cannabis and Medicinal Research is a one of a kind discussion to unite worldwide recognized scholastics in the field of Cannabis and therapeutic, neuroscience and nervous system science, Addiction, Brain analysts, general wellbeing experts, researchers, scholastic researchers, industry specialists, researchers to trade their thoughts in the exploration field of Cannabis Marijuana

Point of this gathering is animate new thoughts for treatment that will be advantageous over the range of Neuroscience.

Gatherings, National symposiums and Workshops give a committed discussion to the progression, execution and trade of data about Neuroscience and its united regions.

Conference Highlights:-

Cannabis

Cannabis Cultivation

Medicinal Plant Chemistry

Extraction techniques

Cannabis & Psychiatry

Addiction

Cannabis Use and Crime

Social Effects of cannabis

Toxicity and Patient Safety

Cannabis-Therapeutics and other Uses

Opioid Effects

Cannabis - Effects on lung health

Why to attend???

• An attractive scientific program

• Interact with the world’s leading professionals

• Certification

• All accepted abstracts for this Congress will be published in the respective Journals

• Each abstract will be labeled with a DOI provided by Cross Ref

• Speaker and Abstract pages created in Google under your name which will attract worldwide acknowledgment to your profile and research

• Handbook & conference Kit

• Extensive exposure globally

Major Associations around the Globe

• National Cannabis Industry Association

• The American Herbal Products Association (AHPA)

• Americans for Safe Access (ASA)

• American Trade Association for Cannabis & Hemp (ATACH)

• The Canadian Medical Cannabis Industry Association

• Hemp Industries Association

• Organic Cannabis Association

• National Hemp Association

• Minority Cannabis Business Association (MCBA)

• Cannabis Canada Association

• Cannabinoids medicals international association for cannabinoids

• Cannabis Trade Associations

• Canadian Medical Cannabis Industry Association (CMCIA)

• Canadian Association of Medical Cannabis Dispensaries (CAMCD)

• Cannabis Patients Association of Canada (CPAC)

• CANADIAN MEDICAL CANNABIS INDUSTRY ASSOCIATION

• CANADIAN MEDICAL CANNABIS INDUSTRY ASSOCIATION

Target Audience:-

• Cannabis Researchers

• Marijuana

• Addiction

• Medicinal Cannabis

• Neurologists

• Neuroscientists

• Board Directors

• Young researches & Students

• Educational institutions

• Neurology Industrialists

• Neurology organizations

• Professors

• Neurology and Neuroscience Researcher’s

• Pharmacists

• Neuropsychologists

• Physicians

• Business delegates

• Experts in care of neurological diseases

Participation Benefits:-

• Accepted Abstracts will be published with DOI number by Cross Ref

• Participation Certificate and Presentation Certificate (for Presenter).

• Handbook & Conference kits.

• Gala lunch and snacks will be served 2 times in a day (for those days of the congress).

• International credits [CPD credits].

• Get worldwide acknowledgement to your profile and Research.

• Publish your compositions in the particular supporting International Journals.

• Best Hospitality services and accommodation at our conference.